SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-323169
Filing Date
2020-12-21
Accepted
2020-12-21 16:31:16
Documents
2
Group Members
ACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL BIOTECHNOLOGY INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d848256dsc13da.htm SC 13D/A 114776
2 EX-99.14 d848256dex9914.htm EX-99.14 9572
  Complete submission text file 0001193125-20-323169.txt   126226
Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Filed by) CIK: 0001391297 (see all company filings)

IRS No.: 721620814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 201404681
SIC: 2834 Pharmaceutical Preparations